GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Womens Health Inc (OTCPK:AWHL) » Definitions » Cyclically Adjusted PB Ratio

AWHL (Aspira Womens Health) Cyclically Adjusted PB Ratio : 0.03 (As of May. 23, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Aspira Womens Health Cyclically Adjusted PB Ratio?

As of today (2025-05-23), Aspira Womens Health's current share price is $0.0592. Aspira Womens Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $2.35. Aspira Womens Health's Cyclically Adjusted PB Ratio for today is 0.03.

The historical rank and industry rank for Aspira Womens Health's Cyclically Adjusted PB Ratio or its related term are showing as below:

AWHL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 1.9   Max: 24.72
Current: 0.03

During the past years, Aspira Womens Health's highest Cyclically Adjusted PB Ratio was 24.72. The lowest was 0.01. And the median was 1.90.

AWHL's Cyclically Adjusted PB Ratio is ranked better than
97.08% of 137 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.91 vs AWHL: 0.03

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Aspira Womens Health's adjusted book value per share data for the three months ended in Mar. 2025 was $-0.002. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.35 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Aspira Womens Health Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Aspira Womens Health's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Womens Health Cyclically Adjusted PB Ratio Chart

Aspira Womens Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.18 5.85 1.20 1.21 0.28

Aspira Womens Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 0.52 0.30 0.28 0.04

Competitive Comparison of Aspira Womens Health's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Aspira Womens Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspira Womens Health's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aspira Womens Health's Cyclically Adjusted PB Ratio falls into.


;
;

Aspira Womens Health Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Aspira Womens Health's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0592/2.35
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Womens Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Aspira Womens Health's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.002/134.9266*134.9266
=-0.002

Current CPI (Mar. 2025) = 134.9266.

Aspira Womens Health Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.272 100.684 4.385
201509 6.379 100.392 8.573
201512 5.051 99.792 6.829
201603 3.707 100.470 4.978
201606 2.731 101.688 3.624
201609 1.805 101.861 2.391
201612 1.078 101.863 1.428
201703 1.749 102.862 2.294
201706 1.209 103.349 1.578
201709 1.480 104.136 1.918
201712 0.851 104.011 1.104
201803 0.310 105.290 0.397
201806 2.405 106.317 3.052
201809 1.932 106.507 2.448
201812 1.421 105.998 1.809
201903 0.722 107.251 0.908
201906 2.124 108.070 2.652
201909 1.824 108.329 2.272
201912 1.347 108.420 1.676
202003 0.817 108.902 1.012
202006 1.084 108.767 1.345
202009 2.098 109.815 2.578
202012 1.393 109.897 1.710
202103 7.025 111.754 8.482
202106 6.269 114.631 7.379
202109 5.152 115.734 6.006
202112 4.036 117.630 4.629
202203 2.909 121.301 3.236
202206 1.886 125.017 2.035
202209 1.347 125.227 1.451
202212 0.840 125.222 0.905
202303 0.099 127.348 0.105
202306 -0.062 128.729 -0.065
202309 -0.064 129.860 -0.066
202312 -0.222 129.419 -0.231
202403 -0.110 131.776 -0.113
202406 -0.289 132.554 -0.294
202409 -0.155 133.029 -0.157
202412 -0.147 133.157 -0.149
202503 -0.002 134.927 -0.002

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aspira Womens Health  (OTCPK:AWHL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Aspira Womens Health Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Aspira Womens Health's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspira Womens Health Business Description

Traded in Other Exchanges
Address
12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Executives
Nicole Sandford director 12117 BEE CAVES RD BLDG 3, STE 100, AUSTIN TX 78738
Minh Hoang Merchant officer: General Counsel & Secretary 1210 AVONDALE ROAD, HILLSBOROUGH CA 94010
Torsten Hombeck officer: Chief Financial Officer 529 W 42ND ST #6V, NEW YORK NY 10036
Celeste Rachelle Fralick director 2801 MESA ROAD, LUBBOCK TX 79403
Veronica Gh Jordan director C/O ALBANY MOLECULAR RESEARCH, INC., 26 CORPORATE CIRCLE, ALBANY NY 12212-5098
Stefanie L. Cavanaugh director 1120 S CAPITAL OF TX HWY, BLDG 1, STE 300, AUSTIN TX 78746
Ellen O'connor Vos director C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Jack W Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Ryan Thinh Phan officer: CSO & COO 327 CARLTON AVE, LOS GATOS CA 95032
Jannie Prestridge Herchuk director 6331 LAVENDALE AVE, DALLAS TX 75230
Winfred Parnell director 6734 TALMADGE LANE, DALLAS TX 75230
Marlene Mclennan officer: Interim Chief Financial Office 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Ruby Sharma director 24 ARNOLD DRIVE, PRINCETON JCT. NJ 08550
Robert D Auerbach director C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588
Valerie Barber Palmieri director, officer: President and CEO 63 INDIAN LEDGE RD., MONROE CT 06468